{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:18:06Z","timestamp":1770347886819,"version":"3.49.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.yexmp.2020.104494","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T03:54:04Z","timestamp":1594785244000},"page":"104494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The role of genetic polymorphism within PD-L1 gene in cancer. Review"],"prefix":"10.1016","volume":"116","author":[{"given":"Agnieszka","family":"Kula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Dawidowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Kiczmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicja","family":"Prawdzic Se\u0144kowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"\u015awi\u0119tochowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0005","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1186\/s13045-019-0779-5","article-title":"Immune checkpoint inhibitors of PD-L1 as cancer therapeutics","volume":"12","author":"Akinleye","year":"2019","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.yexmp.2020.104494_bb0010","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/annonc\/mdu242","article-title":"Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer","volume":"25","author":"Azuma","year":"2014","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0015","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11030310","article-title":"Recent advances in cancer stem cell-targeted immunotherapy","volume":"11","author":"Badrinath","year":"2019","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.yexmp.2020.104494_bb0020","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.yexmp.2020.104494_bb0025","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/PPO.0000000000000059","article-title":"Biochemical signaling of PD-1 on T cells and its functional implications","volume":"20","author":"Boussiotis","year":"2014","journal-title":"Cancer J. (Sudbury, Mass.)"},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus Docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0035","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/hep.28710","article-title":"Programmed death ligand 1 expression in hepatocellular carcinoma: relationship with clinical and pathological features","volume":"64","author":"Calderaro","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.yexmp.2020.104494_bb0040","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1158\/0008-5472.CAN-10-2217","article-title":"B7-H1 overexpression regulates epithelial-mesenchymal transition and accelerates carcinogenesis in skin","volume":"71","author":"Cao","year":"2011","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192385","article-title":"Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer","volume":"13","author":"Catalano","year":"2018","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0050","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/annonc\/mdv615","article-title":"Regulation of PD-L1: a novel role of pro-survival signalling in cancer","volume":"27","author":"Chen","year":"2016","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.yexmp.2020.104494_bb0055","doi-asserted-by":"crossref","first-page":"e364","DOI":"10.5301\/jbm.5000170","article-title":"PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein may be associated with non-small cell lung cancer","volume":"30","author":"Cheng","year":"2015","journal-title":"Int. J. Biol. Markers"},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/imm.12866","article-title":"Cancer stem cells as targets for immunotherapy","volume":"153","author":"Codd","year":"2018","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0065","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/jamaoncol.2020.0726","article-title":"Immune checkpoint inhibitor rechallenge after immune-related adverse events in patients with cancer","volume":"6","author":"Dolladille","year":"2020","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0070","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3892\/mmr.2017.6902","article-title":"Variant SNPs at the microRNA complementary site in the B7-H1 3\u2032-untranslated region increase the risk of non-small cell lung cancer","volume":"16","author":"Du","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.yexmp.2020.104494_bb0075","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/1078-0432.CCR-16-1069","article-title":"Genomic amplification of CD274 (PD-L1) in small-cell lung cancer","volume":"23","author":"George","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0080","first-page":"127","article-title":"Colorectal cancer and NF-\u03baB signaling pathway","volume":"4","author":"Hassanzadeh","year":"2011","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.yexmp.2020.104494_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-0348-0837-8_2","article-title":"The role of inflammation in colon cancer","volume":"816","author":"Janakiram","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexmp.2020.104494_bb0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.yexmp.2020.104494_bb0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2017.00049","article-title":"Current diagnosis and management of Immune Related Adverse Events (irAEs) induced by immune checkpoint inhibitor therapy","volume":"8","author":"Kumar","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexmp.2020.104494_bb0100","article-title":"PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexmp.2020.104494_bb0105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2016.11.007","article-title":"Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer","volume":"599","author":"Lee","year":"2017","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.yexmp.2020.104494_bb0110","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gad.8.9.995","article-title":"A mechanism for TAFs in transcriptional activation: activation domain enhancement of TFIID-TFIIA\u2014promoter DNA complex formation","volume":"8","author":"Lieberman","year":"1994","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.yexmp.2020.104494_bb0115","first-page":"16585","article-title":"Polymorphisms of co-inhibitory molecules (CTLA-4\/PD-1\/PD-L1) and the risk of non-small cell lung cancer in a Chinese population","volume":"8","author":"Ma","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"16","key":"10.1016\/j.yexmp.2020.104494_bb0120","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3760\/cma.j.issn.0366-6999.20122512","article-title":"Clinical significance of costimulatory molecule B7-H3 expression on CD3(+) T cells in colorectal carcinoma","volume":"126","author":"Mao","year":"2013","journal-title":"Chin. Med. J."},{"issue":"52","key":"10.1016\/j.yexmp.2020.104494_bb0125","doi-asserted-by":"crossref","first-page":"20852","DOI":"10.1073\/pnas.0810958105","article-title":"Oncogenic kinase NPM\/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)","volume":"105","author":"Marzec","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.micinf.2011.12.007","article-title":"NLRC5: a newly discovered MHC class I transactivator (CITA)","volume":"14","author":"Meissner","year":"2012","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-019-0733-1","article-title":"The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer","volume":"19","author":"Melissaridou","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0140","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s12032-010-9515-2","article-title":"High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation","volume":"28","author":"Mu","year":"2011","journal-title":"Med. Oncol. (Northwood, London, England)"},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0155","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1074-7613(00)80089-8","article-title":"Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor","volume":"11","author":"Nishimura","year":"1999","journal-title":"Immunity"},{"key":"10.1016\/j.yexmp.2020.104494_bb0160","doi-asserted-by":"crossref","DOI":"10.1038\/srep45124","article-title":"Clinical impact of single nucleotide polymorphism in PD-L1 on response to nivolumab for advanced non-small-cell lung cancer patients","volume":"7","author":"Nomizo","year":"2017","journal-title":"Sci. Rep."},{"issue":"34","key":"10.1016\/j.yexmp.2020.104494_bb0165","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1038\/onc.2008.118","article-title":"Snai1 and Snai2 collaborate on tumor growth and metastasis properties of mouse skin carcinoma cell lines","volume":"27","author":"Olmeda","year":"2008","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0170","first-page":"1097","article-title":"The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo","volume":"187","author":"Paterson","year":"2011","journal-title":"J.I."},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0175","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12015-018-9860-7","article-title":"PD-L1 expression on lung cancer stem cells in metastatic lymph nodes aspirates","volume":"15","author":"Raniszewska","year":"2019","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.oraloncology.2014.11.014","article-title":"Intrinsic and extrinsic control of expression of the immunoregulatory molecule PD-L1 in epithelial cells and squamous cell carcinoma","volume":"51","author":"Ritprajak","year":"2015","journal-title":"Oral Oncol."},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0185","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1151593","article-title":"NLRC5 elicits antitumor immunity by enhancing processing and presentation of tumor antigens to CD8+ T lymphocytes","volume":"5","author":"Rodriguez","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.yexmp.2020.104494_bb0190","series-title":"Regulation of Cancer Immune Checkpoints","first-page":"83","article-title":"Mechanisms of resistance to checkpoint blockade therapy","author":"Shi","year":"2020"},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0195","first-page":"674","article-title":"Keratinocyte-specific Pten deficiency results in epidermal hyperplasia, accelerated hair follicle morphogenesis and tumor formation","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0200","first-page":"287","article-title":"Correlation of PD-1\/PD-L1 polymorphisms and expressions with clinicopathologic features and prognosis of ovarian cancer","volume":"21","author":"Tan","year":"2018","journal-title":"Cancer Biomark. Sect. A Dis. Markers"},{"issue":"24","key":"10.1016\/j.yexmp.2020.104494_bb0205","doi-asserted-by":"crossref","first-page":"36590","DOI":"10.18632\/oncotarget.9096","article-title":"Genetic alteration profiling of patients with resected squamous cell lung carcinomas","volume":"7","author":"Tao","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0210","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00262-016-1936-0","article-title":"A polymorphism in the promoter region of PD-L1 serves as a binding-site for SP1 and is associated with PD-L1 overexpression and increased occurrence of gastric cancer","volume":"66","author":"Tao","year":"2017","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0215","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10875-007-9113-z","article-title":"Polymorphisms of genes for programmed cell death 1 ligands in patients with rheumatoid arthritis","volume":"27","author":"Wang","year":"2007","journal-title":"J. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0220","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/humu.22014","article-title":"A frequent somatic mutation in CD274 3\u2019-UTR leads to protein over-expression in gastric cancer by disrupting miR-570 binding","volume":"33","author":"Wang","year":"2012","journal-title":"Hum. Mutat."},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00439-013-1275-6","article-title":"A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma","volume":"132","author":"Wang","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.yexmp.2020.104494_bb0230","first-page":"2","article-title":"The roles of the PD-1\/PD-L1 pathway at immunologically privileged sites","volume":"78","author":"Wang","year":"2017","journal-title":"Am. J. Reprod. Immunol. (New York, N.Y. 1989)"},{"issue":"10","key":"10.1016\/j.yexmp.2020.104494_bb0235","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00262-017-2017-8","article-title":"A gene polymorphism in PD-L1 promoter region is not associated with PD-L1 expression and patients\u2019 survival in gastric cancer","volume":"66","author":"Wang","year":"2017","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.yexmp.2020.104494_bb0240","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27763","article-title":"Toll-like receptor genetic variants and colorectal cancer","volume":"3","author":"Weber","year":"2014","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002352","article-title":"Type 1 interferons and antiviral CD8 T-cell responses","volume":"8","author":"Welsh","year":"2012","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0250","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/gmic.19320","article-title":"The role of gut microbiota in immune homeostasis and autoimmunity","volume":"3","author":"Wu","year":"2012","journal-title":"Gut Microbes"},{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0255","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.acthis.2006.01.003","article-title":"Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance","volume":"108","author":"Wu","year":"2006","journal-title":"Acta Histochem."},{"issue":"5","key":"10.1016\/j.yexmp.2020.104494_bb0260","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/1440-1681.12732","article-title":"Increased PD-L1 expression in breast and colon cancer stem cells","volume":"44","author":"Wu","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yexmp.2020.104494_bb0265","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.gene.2018.06.069","article-title":"Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population","volume":"674","author":"Xie","year":"2018","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"2","key":"10.1016\/j.yexmp.2020.104494_bb0275","first-page":"e1","article-title":"Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population","volume":"10","author":"Y-b","year":"2014","journal-title":"Asia-Pac. J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2020.104494_bb0280","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.humpath.2017.08.016","article-title":"Association of PD-L1 expression and PD-L1 gene polymorphism with poor prognosis in lung adenocarcinoma and squamous cell carcinoma","volume":"68","author":"Yeo","year":"2017","journal-title":"Hum. Pathol."},{"issue":"6","key":"10.1016\/j.yexmp.2020.104494_bb0285","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1084\/jem.20112741","article-title":"Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2","volume":"209","author":"Yokosuka","year":"2012","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.yexmp.2020.104494_bb0290","doi-asserted-by":"crossref","first-page":"288","DOI":"10.21037\/tlcr.2016.06.07","article-title":"Non-small cell lung cancer: current treatment and future advances","volume":"5","author":"Zappa","year":"2016","journal-title":"Transl. Lung Cancer Res."},{"issue":"8","key":"10.1016\/j.yexmp.2020.104494_bb0295","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1021\/jp409778e","article-title":"The catalytic mechanism of histone acetyltransferase p300: from the proton transfer to acetylation reaction","volume":"118","author":"Zhang","year":"2014","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.yexmp.2020.104494_bb0300","first-page":"65","article-title":"Programmed death-1 ligand-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers","volume":"21","author":"Zhou","year":"2017","journal-title":"Cancer Biomark. Sect. A Dis. Markers"},{"issue":"8","key":"10.1016\/j.yexmp.2020.104494_bb0305","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4161\/onci.21335","article-title":"Targeting PD-1\/PD-L1 interactions for cancer immunotherapy","volume":"1","author":"Zitvogel","year":"2012","journal-title":"Oncoimmunology"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448002030770X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448002030770X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:00:09Z","timestamp":1757991609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448002030770X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":59,"alternative-id":["S001448002030770X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104494","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of genetic polymorphism within PD-L1 gene in cancer. Review","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104494","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104494"}}